HomeORGANIZATION
ORGANIZATION

Kenporen’s Kono Pushes for “Huge Seller” Re-Pricing for Opdivo before 2018
(Sep.7.2016)

Kenporen Director Shoji Kono
The reimbursement price of Opdivo (nivolumab) should be slashed through a new special re-pricing rule for fast-growing blockbusters without waiting for the next drug price revision scheduled for April 2018, Shoji Kono, director of the National Federation of Health Insurance Societies (Kenporen), told Jiho ...
(LOG IN FOR FULL STORY)

News Calendar